The two-week moving average of new COVID-19 cases dropped more than 10 percent, adding to evidence that the coronavirus is at least temporarily in retreat.
Search results for:
Merck said it will soon ask health officials to authorize the pill’s use. A decision from the U.S. Food and Drug Administration could come within weeks after that.